-Clinical Practice Guidelines.
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. European Association for the Study of the Liver
-CT/MRI LI-RADS® v2018 American College of Radology
-Hepatocellular carcinoma.
Lancet.
2018.
Mar 31; 391(10127):1301-1314. Forner A,
Reig M,
Bruix J.
-Hepatic resection vs.
radiofrequency ablation for very early stage hepatocellular carcinoma: a Markov model analysis.
Cho YK,
Kim JK,
Kim WT,
Chung JW.
Hepatology 2010; 51:1284–1290.
-Cost-effectiveness of hepatic resection vs.
percutaneous radiofre- quency ablation for early hepatocellular carcinoma.
Cucchetti A,
Piscaglia F,
Cescon M,
Colecchia A,
Ercolani G,
Bolondi L,
et al.
J Hepatol 2013;59:300–307.
-Transarterial Radioembolization with Yttrium-90 for the treatment of Hepatocellular Carcinoma.
Joseph Ralph Kallini,
Ahmed Gabr,
Riad Salem and Robert J.Lewansdowski.
Adv.Ther.
2016; 33: 699–714.
-Stereotactic body radiation therapy (SBRT) for definitive tratment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma.
Assaf Moore,
Michal Cohen-Naftaly,
Anna Tobar,
Yulia Kundel,
Ofer Benjaminov,
Mariud Braun,
Assaf Issachar,
Eytam Mor, Michal Sarfaty,
Dimitri Bragilovjki,
Ran Ben Hur,
Noa Gordon,
Salomon M.
Stemmer,
and Aaron M.
Allen.
Radiot Oncol.
2017; 12:163